We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Sanofi | EU:SAN | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 91.90 | 100.00 | 88.00 | 0.00 | 06:53:47 |
From May 2019 to May 2024
By Jaime Llinares Taboada
Beximco Pharmaceuticals Ltd. said Thursday that it has entered into an agreement with Sanofi S.A. to buy a majority stake in Sanofi Bangladesh Ltd.
The AIM-listed pharmaceutical company said it will pay an adjustable consideration of 35.5 million pounds ($48.5 million) for Sanofi's 54.6% stake in the Bangladeshi company. The remaining stake is held by the government of Bangladesh.
Sanofi Bangladesh has over 800 employees and produces approximately 100 branded generic products, in addition to importing and supplying vaccines, insulins and chemotherapy drugs. The group made a pretax profit of around GBP4.3 million in 2019.
Beximco said the acquisition would help it to consolidate its leading position in Bangladesh. The deal is expected to complete within three to nine months.
Shares in Beximco at 0949 GMT were down 0.1% at 195.3 pence. Sanofi was flat at EUR82.35.
Write to Jaime Llinares Taboada at jaime.llinares@wsj.com; @JaimeLlinaresT
(END) Dow Jones Newswires
January 21, 2021 05:09 ET (10:09 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
